COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03OPS
|
|||
Drug Name |
HR2P-M2 peptide
|
|||
Synonyms |
HR2P-M2
|
|||
Drug Type |
Protein/peptide drug
|
|||
Indication | Middle East Respiratory Syndrome (MERS) | Preclinical | [1] | |
Therapeutic Class |
Antiviral Agents
|
Target | Top | |||
---|---|---|---|---|
Target(s) | MERS-CoV spike glycoprotein S2 subunit (S S2) | Target Info | Inhibitor | [1] |
HR2P-M2 is a HR2P mutant, whose anti-MERS-CoV activity is improved by more stablely binding to MERS-CoV spike protein S2 subunit. |
References | Top | |||
---|---|---|---|---|
1 | Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun. 2014;5:3067. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.